Genus Capital Management Inc. Merck & Co., Inc. Transaction History
Genus Capital Management Inc.
- $763 Billion
- Q3 2024
A detailed history of Genus Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Genus Capital Management Inc. holds 58,591 shares of MRK stock, worth $5.76 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
58,591
Previous 151,373
61.29%
Holding current value
$5.76 Million
Previous $18.7 Billion
64.5%
% of portfolio
0.87%
Previous 2.47%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.46 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.82 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...